|
Market Closed -
NYSE
16:00:00 2025-07-24 EDT
|
5-day change | 1st Jan Change | ||
| 11.13 USD | +0.27% |
|
-.--% | - |
| 25-07-27 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Biotechnology Select Industry Index | CI |
| 25-07-27 | Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Global BMI Index | CI |
Upcoming events on VERE THER
No events available
Past events on VERE THER
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,94 1,02 89.82% | 11,8 7,54 56.03% | 32,3 23,9 35.54% |
|
EBITDA Million USD | Released Forecast Spread | -163 -154 -6.05% | -218 -226 3.57% | -222 -234 5.04% |
|
EBIT Million USD | Released Forecast Spread | -166 -161 -2.85% | -223 -224 0.47% | -229 -236 3.1% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -157 -158 0.51% | -200 -206 2.8% | -198 -210 5.61% |
|
Net income Million USD | Released Forecast Spread | -157 -158 0.47% | -200 -206 2.77% | -199 -210 5.52% |
|
EPS USD | Released Forecast Spread | -2,91 -3,02 3.61% | -3,12 -3,29 5.17% | -2,35 -2,50 5.97% |
| Announcement Date | 02/03/23 | 27/02/24 | 27/02/25 |
Quarterly results
| Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,12 1,08 187.51% | 5,14 1,17 340.7% | 5,70 2,25 153.11% | 6,69 2,71 146.89% | 6,87 3,26 110.87% | 13,1 4,24 208.65% | 33,0 9,38 251.72% |
|
EBITDA Million USD | Released Forecast Spread | -50,9 -62,0 17.97% | -55,2 -62,0 10.95% | -57,2 -65,0 12.04% | -34,9 -75,0 53.44% | |||
|
EBIT Million USD | Released Forecast Spread | -52,3 -60,2 13.1% | -53,9 -57,3 5.83% | -56,8 -57,7 1.49% | -58,8 -61,2 3.9% | -56,9 -64,1 11.25% | -56,1 -64,7 13.33% | -36,6 -61,2 40.16% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -45,7 -58,1 21.31% | -48,3 -54,1 10.75% | -48,6 -55,1 11.76% | -49,7 -57,0 12.67% | -50,0 -59,2 15.49% | -50,0 -60,2 16.94% | -31,0 -59,2 47.71% |
|
Net income Million USD | Released Forecast Spread | -45,8 -58,1 21.2% | -48,4 -54,1 10.7% | -48,7 -55,1 11.57% | -49,8 -57,0 12.57% | -50,1 -59,2 15.33% | -50,0 -60,1 16.78% | -31,0 -59,2 47.58% |
|
EPS USD | Released Forecast Spread | -0,72 -0,92 21.45% | -0,69 -0,82 15.46% | -0,59 -0,71 17.29% | -0,59 -0,68 13.49% | -0,59 -0,70 16.01% | -0,58 -0,69 16.15% | -0,35 -0,67 47.88% |
| Announcement Date | 07/11/23 | 27/02/24 | 08/05/24 | 08/08/24 | 05/11/24 | 27/02/25 | 14/05/25 |
Past sector events for VERE THER
- Stock Market
- Stocks
- VERV Stock
- Calendar VERE THER
Select your edition
All financial news and data tailored to specific country editions
